logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Ron Ogilvie

teva pharmaceutical industries

5H指数
12论文数
144被引数
收录论文 3
发表时间
logo
Qualification of impurities based on metabolite data
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2020-02-01
err12
PREAI
errWeidolf, Lars; Andersson, Thomas; Bercu, Joel P.; Brink, Andreas; Glowienke, Susanne; Harvey, James; Hayes, Martin A.; Jacques, Pascale; Lu, Chuang; Manevski, Nenad; Muster, Wolfgang; Nudelman, Raphael; Ogilvie, Ron; Ottosson, Jenny; Teasdale, Andrew; Trela, Bruce
err分享
err收藏
Regulatory Highlights
errORGANIC PROCESS RESEARCH & DEVELOPMENT
IF3.5
err2018-07-05
err0
PREAI
errTeasdale, Andrew; Popkin, Matthew; Ogilvie, Ron
err分享
err收藏
Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development
errREGULATORY TOXICOLOGY AND PHARMACOLOGY
IF3.5
err2017-03-01
err35
PREAI
errHarvey, James; Fleetwood, Andrew; Ogilvie, Ron; Teasdale, Andrew; Wilcox, Phil; Spanhaak, Steven
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
T
Thomas Andersson
H 指数: 33 · 论文数: 237
A
Andrew Teasdale
H 指数: 32 · 论文数: 130
A
Andrew J. Fleetwood
H 指数: 32 · 论文数: 59
M
Martin A. Hayes
H 指数: 30 · 论文数: 157
L
Lars Weidolf
H 指数: 28 · 论文数: 67
查看更多